ANI Pharmaceuticals | ANIP - Current Assets


ANI Pharmaceuticals reported $698.4M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
ANI Pharmaceuticals USD 698.4M 95.77M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Novartis USD 28.2B 2.26B Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025